Literature DB >> 18298898

NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.

Ling Qiao1, Tie-jun Zhao, Feng-ze Wang, Chang-liang Shan, Li-hong Ye, Xiao-dong Zhang.   

Abstract

AIM: It has been reported that stem cells are able to home to tumorigenesis and inhibit the proliferation of tumor cells. The purpose of our study was to demonstrate the molecular mechanism of the inhibitory proliferation of hepatoma cells and breast cancer cells mediated by human mesenchymal stem cells (hMSCs).
METHODS: The proliferation of H7402 human hepatoma cells and MCF-7 human breast cancer cells was measured by the 5-bromodeoxyuridine (BrdU) incorporation assay and flow cytometry assay after the treatment with conditioned media from hMSCs culture, such as Z3 cells or BMMS-03 cells. The role of NF-kappaB or the phosphorylation of inhibitor kappaBalpha (p-IkappaBalpha) in the depression of hepatoma or breast cancer cells treated with conditioned media from Z3 cells or BMMS-03 cells was examined by reporter gene assay, quantitative real-time PCR, and Western blot analysis, respectively.
RESULTS: The proliferation of H7402 cells and MCF-7 cells was decreased significantly by the BrdU incorporation assay and flow cytometry assay after treatment. The transcriptional activity and mRNA level of NF-kappaB were downregulated in the treated cells by reporter gene assay and quantitative real-time PCR in a dose-dependent manner. At the protein level, NF-kappaB and p-IkappaBalpha decreased in the treated cells by Western blot analysis.
CONCLUSION: Conditioned media from hMSCs are able to inhibit the proliferation of tumor cells. NF-kappaB downregulation is one of reasons for the depression of tumor cell proliferation mediated by hMSCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298898     DOI: 10.1111/j.1745-7254.2008.00751.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  25 in total

1.  Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway.

Authors:  Wen-jing Cui; Yi Liu; Xiao-lei Zhou; Feng-ze Wang; Xiao-dong Zhang; Li-hong Ye
Journal:  Acta Pharmacol Sin       Date:  2010-05-10       Impact factor: 6.150

Review 2.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

Review 3.  Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

Authors:  Qi Bao; Yue Zhao; Hanno Niess; Claudius Conrad; Bettina Schwarz; Karl-Walter Jauch; Ralf Huss; Peter J Nelson; Christiane J Bruns
Journal:  Stem Cells Dev       Date:  2012-06-26       Impact factor: 3.272

4.  Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells.

Authors:  J Zhang; L Hou; D Zhao; M Pan; Z Wang; H Hu; J He
Journal:  Clin Transl Oncol       Date:  2017-07-21       Impact factor: 3.405

5.  Co-culture of hepatoma cells with hepatocytic precursor (stem-like) cells inhibits tumor cell growth and invasion by downregulating Akt/NF-κB expression.

Authors:  Cheng-Jun Sui; Miao Xu; Wei-Qing Li; Jia-Mei Yang; Hong-Zhu Yan; Hui-Min Liu; Chun-Yan Xia; Hong-Yu Yu
Journal:  Oncol Lett       Date:  2016-09-13       Impact factor: 2.967

Review 6.  Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy.

Authors:  Parisa Lotfinegad; Karim Shamsasenjan; Aliakbar Movassaghpour; Jafar Majidi; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-12-23

7.  Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.

Authors:  Xu-Yong Sun; Jiang Nong; Ke Qin; Garth L Warnock; Long-Jun Dai
Journal:  World J Stem Cells       Date:  2011-11-26       Impact factor: 5.326

8.  Hippocampal CysLT1R knockdown or blockade represses LPS-induced depressive behaviors and neuroinflammatory response in mice.

Authors:  Jing-Ran Lin; Shun-Chang Fang; Su-Su Tang; Mei Hu; Yan Long; Arijit Ghosh; Hong-Bin Sun; Ling-Yi Kong; Hao Hong
Journal:  Acta Pharmacol Sin       Date:  2017-01-23       Impact factor: 6.150

9.  Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

Authors:  Michael R Loebinger; Ayad Eddaoudi; Derek Davies; Sam M Janes
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

Review 10.  Stem cells as vectors for antitumour therapy.

Authors:  Michael R Loebinger; Sam M Janes
Journal:  Thorax       Date:  2010-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.